- Home
- ETON vs KFS Comparison
ETON vs KFS Comparison
Compare ETON & KFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETON
- KFS
- Stock Information
- Founded
- ETON 2017
- KFS 1989
- Country
- ETON United States
- KFS United States
- Employees
- ETON 31
- KFS N/A
- Industry
- ETON Biotechnology: Pharmaceutical Preparations
- KFS Property-Casualty Insurers
- Sector
- ETON Health Care
- KFS Finance
- Exchange
- ETON Nasdaq
- KFS Nasdaq
- Market Cap
- ETON 498.8M
- KFS 437.4M
- IPO Year
- ETON 2018
- KFS 1996
- Fundamental
- Price
- ETON $18.25
- KFS $13.92
- Analyst Decision
- ETON Strong Buy
- KFS
- Analyst Count
- ETON 3
- KFS 0
- Target Price
- ETON $29.67
- KFS N/A
- AVG Volume (30 Days)
- ETON 261.2K
- KFS 66.9K
- Earning Date
- ETON 11-06-2025
- KFS 11-06-2025
- Dividend Yield
- ETON N/A
- KFS N/A
- EPS Growth
- ETON N/A
- KFS N/A
- EPS
- ETON N/A
- KFS N/A
- Revenue
- ETON $58,181,000.00
- KFS $119,287,000.00
- Revenue This Year
- ETON $105.25
- KFS N/A
- Revenue Next Year
- ETON $40.84
- KFS N/A
- P/E Ratio
- ETON N/A
- KFS N/A
- Revenue Growth
- ETON 85.40
- KFS 12.05
- 52 Week Low
- ETON $8.24
- KFS $7.06
- 52 Week High
- ETON $23.00
- KFS $16.80
- Technical
- Relative Strength Index (RSI)
- ETON 46.28
- KFS 42.45
- Support Level
- ETON $18.00
- KFS $14.55
- Resistance Level
- ETON $18.92
- KFS $15.29
- Average True Range (ATR)
- ETON 0.87
- KFS 0.57
- MACD
- ETON -0.12
- KFS -0.11
- Stochastic Oscillator
- ETON 40.66
- KFS 3.07
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
About KFS Kingsway Financial Services Inc. (DE)
Kingsway Financial Services Inc through subsidiaries operates in the extended warranty and business services industries in the United States. The company operates through segments namely, Extended Warranty and Kingsway Search Xcelerator. The Extended Warranty segment provides after-market vehicle protection services distributed by credit unions. The firm generates maximum revenue from the Extended Warranty segment in the form of Service fee and commission income.